Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

serko-sko-crush-asx-200
Today's ASX news
Owen Raszkiewicz

CSL Share Price Jumps On Profit

The CSL Limited (ASX:CSL) share price jumped 3% on Wednesday after the global biopharmaceutical company released its 2018 financial results. 

ASX-News-
Today's ASX news
Rask Invest Research Team

S&P/ASX 200 Pre Market News

Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Wednesday morning.

Skip to content